c-Met responsiveness of isolated hepatocytes evaluated in an in vitro de-differentiation model

International Journal of Molecular Medicine

Volumn 17, Issue 3, 2006, Pages 475-482

  Boost, Kim A ^a   Kim, He Jin ^a   Engl, Tobias ^a   Oppermann, Elsie ^a   Jonas, Dietger ^a   Oertl, Anton ^a   Blaheta, Roman A ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

ASGPr; c Met; Cirrhosis; De differentiation; Hepatocytes

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR; COLLAGEN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TAUROCHENODEOXYCHOLIC ACID; TAUROURSODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL CULTURE; CELL DIFFERENTIATION; CELL SHAPE; CULTURE MEDIUM; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL LIVER CIRRHOSIS; GENETICS; LIVER CELL; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; ASIALOGLYCOPROTEIN RECEPTOR; CELL DIFFERENTIATION; CELL SHAPE; CELLS, CULTURED; COLLAGEN; CULTURE MEDIA, SERUM-FREE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MODELS, BIOLOGICAL; PROTO-ONCOGENE PROTEINS C-MET; RATS; RATS, SPRAGUE-DAWLEY; TAUROCHENODEOXYCHOLIC ACID; UP-REGULATION; URSODEOXYCHOLIC ACID;

EID: 33644946812     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.17.3.475     Document Type: Article

References (32)

1. Hernández-Muñoz R, Diaz-Muñoz M, Suárez-Cuenca S, Trejo-Solis T, Lopez V, Sanchez-Sevilla L, Yanez L and De Sanchez VC: Adenosine reverses a preestablished CCl4-induced micronodular cirrhosis through enchancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats. Hepatology 34: 677-687, 2001.
2. Birchmeier C and Gherardi E: Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 8: 404-409, 1998.
3. Matsumoto K and Nakamura T: Emerging multipotent aspects of hepatocyte growth factor. J Biochem 119: 591-600, 1996. (Pubitemid 26131762)
4. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K and Nakamura T: Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 16: 1227-1235, 1992.
5. Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T and Higashio K: Anti-fibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 24: 636-642, 1996. (Pubitemid 26296009)
6. Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y, Nishiyama E and Nakamura T: Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 26: 81-89, 1997.
7. Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R, Matsumoto K, Nakamura T, Takahashi H, Okamoto E and Fujimoto J: Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 5: 226-230, 1999. (Pubitemid 29068532)
8. Kim WH, Matsumoto K, Bessho K and Nakamura T: Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Am J Pathol 166: 1017-1028, 2005. (Pubitemid 40524427)
9. Xue F, Takahara T, Yata Y, Kuwabara Y, Shinno E, Nonome K, Minemura M, Takahara S, Li X, Yamato E and Watanabe A: Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy. Gut 52: 694-700, 2003.
10. Andiran F, Ayhan A, Tanyel FC, Abbasoglu O and Sayek I: Regenerative capacities of normal and cirrhotic livers following 70% hepatectomy in rats and the effect of α-tocopherol on cirrhotic regeneration. J Surg Res 89: 184-188, 2000. (Pubitemid 30196523)
11. Kawasaki S, Imamura H, Bandai Y, Sanjo K and Idezuki Y: Direct evidence for the intact hepatocyte theory in patients with liver cirrhosis. Gastroenterology 102: 1351-1355, 1992.
12. Hashimoto M and Watanabe G: Functional capacity of the cirrhotic liver after partial hepatectomy in the rat. Surgery 126: 541-547, 1999. (Pubitemid 29421042)
13. Kaido T, Oe H, Yoshikawa A, Okajima A and Imamura M: Expressions of molecules associated with hepatocyte growth factor activation after hepatectomy in liver cirrhosis. Hepatogastroenterology 51: 547-551, 2004.
14. Cramer T, Schuppan D, Bauer M, Pfander D, Neuhaus P and Herbst H: Hepatocyte growth factor and c-Met expression in rat and human liver fibrosis. Liver Int 24: 335-344, 2004.
15. Ise H, Nikaido T, Negishi N, Sugihara N, Suzuki F, Akaide T and Ikeda U: Effective hepatocyte transplantation using rat hepatocytes with low asialoglycoprotein receptor expression. Am J Pathol 165: 501-510, 2004.
16. Blaheta RA, Kronenberger B, Woitaschek D, Auth MK, Scholz M, Weber S, Schuldes H, Encke A and Markus BH: Dedifferentiation of human hepatocytes by extracellular matrix proteins in vitro: quantitative and qualitative investigation of cytokeratin 7, 8, 18, 19 and vimentin filaments. J Hepatol 28: 677-690, 1998.
17. Auth MK, Boost KA, Leckel K, Beecken WD, Engl T, Jonas D, Oppermann E, Hilgard P, Markus BH, Bechstein WO and Blaheta RA: Controlled and reversible induction of differentiation and activation of adult human hepatocytes by a biphasic culture technique. World J Gastroenterol 11: 2080-2087, 2005.
18. Pani G, Fusco S, Colavitti R, Borrello S, Maggiano N, Cravero AA, Farre SM, Galeotti T and Koch OR: Abrogation of hepatocyte apoptosis and early appearance of liver dysplasia in ethanol-fed p53-deficient mice. Biochem Biophys Res Commun 325: 97-100, 2004. (Pubitemid 39441166)
19. Lemmer ER, De la Motte Hall P, Omori N, Omori M, Shephard EG, Gelderblom WC, Cruse JP, Barnard RA, Marasas WF, Kirsch RE and Thorgeirsson SS: Histopathology and gene expression changes in rat liver during feeding of fumonisin B1, a carcinogenic mycotoxin produced by Fusarium moniliforme. Carcinogenesis 20: 817-824, 1999.
20. Stella MC, Trusolino L, Pennacchietti S and Comoglio PM: Negative feedback regulation of Met-dependent invasive growth by Notch. Mol Cell Biol 25: 3982-3996, 2005.
21. Paumgartner G and Beuers U: Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis 8: 67-81, 2004. (Pubitemid 38373670)
22. Caglieris S, Giannini E, Dardano G, Mondello L, Valente U and Testa R: Tauroursodeoxycholic acid administration as adjuvant therapy in cirrhotic patients on transplantation waiting lists. Hepatogastroenterology 47: 1045-1047, 2000.
23. Fang Y, Han SI, Mitchell C, Gupta S, Studer E, Grant S, Hylemon PB and Dent P: Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytes. Hepatology 40: 961-971, 2004. (Pubitemid 39288130)
24. Rao YP, Studer EJ, Stravitz RT, Gupta S, Qiao L, Dent P and Hylemon PB: Activation of the Raf-1/MEK/ERK cascade by bile acids occurs via the epidermal growth factor receptor in primary rat hepatocytes. Hepatology 35: 307-314, 2002.
25. Tomita K, Azuma T, Kitamura N, Nishida J, Tamiya G, Oka A, Inokuchi S, Nishimura T, Suematsu M and Ishii H: Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met. Gastroenterology 126: 873-885, 2004.
26. Moghe PV, Berthiaume F, Ezzell RM, Toner M, Tompkins RG and Yarmush ML: Culture matrix configuration and composition in the maintenance of hepatocyte polarity and function. Biomaterials 17: 373-385, 1996.
27. Michalopoulos GK, Bowen WC, Zajac VF, Beer-Stolz D, Watkins S, Kostrubsky V and Strom SC: Morphogenetic events in mixed cultures of rat hepatocytes and nonparenchymal cells maintained in biological matrices in the presence of hepatocyte growth factor and epidermal growth factor. Hepatology 29: 90-100, 1999.
28. Cheng K, Ye Z, Guntaka RV and Mahato RI: Biodistribution and hepatic uptake of triplex-forming oligonucleotides against type alpha1(I) collagen gene promoter in normal and fibrotic rats. Mol Pharm 2: 206-217, 2005.
29. Stefanovic L, Stephens CE, Boykin D and Stefanovic B: Inhibitory effect of dicationic diphenylfurans on production of type I collagen by human fibroblasts and activated hepatic stellate cells. Life Sci 76: 2011-2026, 2005.
30. Saito T, Kwon AH, Qiu Z, Tsuchiya H, Tsuji K and Kamiyama Y: Protective effect of fibronectin for endotoxin-induced liver injury after partial hepatectomy in rats. J Surg Res 124: 79-84, 2005. (Pubitemid 40269805)
31. Nakamura K, Yokohama S, Yoneda M, Okamoto S, Tamaki Y, Ito T, Okada M, Aso K and Makino I: High, but not low, molecular weight hyaluronan prevents T-cell-mediated liver injury by reducing proinflammatory cytokines in mice. J Gastroenterol 39: 346-354, 2004.
32. Blaheta RA, Kronenberger B, Woitaschek D, Schick C, Oppermann E, Auth MK, Strain AJ, Weber S, Encke A and Markus BH: Interference of soluble mediators into liver matrix triggered dedifferentiation of human hepatocytes. Transplant Proc 31: 502-504, 1999.